IA
BRTX icon

IFP Advisors’s BioRestorative Therapies BRTX Stock Holding History

IFP Advisors’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$2K – 4623
2022
Q3 		$2K Hold
2
– – ﹤0.01% 4321
2022
Q2 		$2K Hold
2
– – ﹤0.01% 4089
2022
Q1 		$2K Buy
+2
New +$9 ﹤0.01% 4089

Other funds holding BRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors's BRTX Position: Q4 2022 in Review

IFP Advisors sold out of BioRestorative Therapies (BRTX) in Q4 2022, closing a stake of 2 shares — an estimated $2K sold.

IFP Advisors first reported a position in BRTX in Q1 2022 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 15 funds tracked by Wall St. Rank hold BRTX as of Q4 2022.

  • IFP Advisors reported no remaining BioRestorative Therapies position as of Q4 2022 after selling out during the quarter.
  • IFP Advisors sold 2 BioRestorative Therapies shares in Q4 2022, an estimated $2K.
  • IFP Advisors first reported a position in BioRestorative Therapies in Q1 2022 and held it in 3 quarters.
  • IFP Advisors's BioRestorative Therapies position peaked at $2K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q4 2022.

Based on IFP Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.